What Changed
Price Move History
- Daily moves over 5%
- 90 247 sessions, November 13, 2025 to November 6, 2026
- Largest daily move
- -83.5% close of February 13, 2026
- 1-month change
- -68.6% closing prices, October 6, 2026 to November 6, 2026
Company Description
Phaos Technology Holdings (Cayman) Limited (POAS) is an investment holding company incorporated in the Cayman Islands whose business is centered on advanced microscopy technology. Through its operating subsidiaries, including Phaos Technology Pte. Ltd., the company focuses on advanced microscopy solutions, combining specialized hardware and software to enhance optical imaging for professional and industrial users.
The company is described as an advanced microscopy technology company and an advanced microscopy solutions company,> with operations connected to Singapore, where it is headquartered. Its activities include the research, development, manufacturing, and commercialization of advanced optical technologies and products. According to available information, Phaos utilizes patented microsphere technology designed to enhance the magnification capabilities of traditional optical microscopes. This technology aims to enable visualization beyond the conventional 200 nm optical limit at a working distance that is described as commercially viable.
Phaos offers advanced microscopy equipment and parts together with software solutions powered by artificial intelligence. These software offerings are positioned as complementary to the hardware, with the goal of delivering integrated microscopy systems that combine optical components and AI-enabled software. The company states that its microscopy products and software solutions are used across diverse sectors, including manufacturing, biomedical, and research.
Business model and activities
Based on available descriptions, Phaos Technology Holdings (Cayman) Limited functions as an investment holding company at the group level, while its subsidiaries engage directly in the development and commercialization of microscopy technology and products. The business involves creating and supplying advanced microscopy equipment and related parts, as well as providing AI-powered software that works with this hardware.
The company emphasizes advanced optical technologies and the use of microsphere technology to push beyond traditional optical limits. Its integrated systems are positioned for use in professional settings where high-resolution imaging is important, such as industrial manufacturing environments, biomedical applications, and scientific research.
Technology focus
Phaos highlights its patented microsphere technology as a core element of its optical approach. This technology is described as enhancing the magnification of traditional optical microscopes and enabling visualization beyond the 200 nm optical limit while maintaining a working distance that is stated to be commercially viable. The company also emphasizes the role of artificial intelligence in its software solutions, which are designed to complement the hardware and form part of fully integrated microscopy systems.
Markets and applications
The company indicates that its technologies and solutions serve manufacturing, biomedical, and research sectors. Within these broad areas, advanced microscopy and high-resolution imaging can be relevant for quality control, inspection, analysis, and scientific investigation. Phaos positions its microscopy products and AI-powered software as tools that can be applied across these different types of users and use cases.
Listing and regulatory context
Phaos Technology Holdings (Cayman) Limited’s class A ordinary shares trade on the NYSE American under the ticker symbol "POAS". The company completed an initial public offering of class A ordinary shares, conducted pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission. Following the IPO, an over-allotment option for additional class A ordinary shares was exercised in full by the underwriters, as disclosed in a Form 6-K current report filed as a foreign private issuer.
The company’s SEC filings, including its Form F-1 registration statement and Form 6-K reports, provide additional detail on its corporate structure as a Cayman Islands exempted company, its role as an investment holding company for its operating subsidiaries, and the terms of its securities offerings.
Corporate structure and location
Phaos Technology Holdings (Cayman) Limited is incorporated in the Cayman Islands as an exempted company. It is described as the investment holding company of Phaos Technology Pte. Ltd., which is referred to as an advanced microscopy solutions company. The group is described in public communications as being headquartered in Singapore, with principal executive offices located in Singapore Science Park, according to its Form 6-K filing.
Summary
In summary, Phaos Technology Holdings (Cayman) Limited (POAS) is a Cayman Islands–incorporated investment holding company for an advanced microscopy technology business headquartered in Singapore. Through its subsidiaries, it focuses on advanced optical technologies, patented microsphere-based microscopy, and AI-powered software, offering microscopy equipment, parts, and integrated systems that are described as applicable to manufacturing, biomedical, and research sectors. Its class A ordinary shares are listed on the NYSE American, and the company provides regulatory disclosures through SEC filings such as Form F-1 and Form 6-K.
Stock Performance
Phaos Technology Holdings (Cayman) (POAS) closed at $0.7300 on November 6, 2026. So far this year, the price has lost 98.6%.
POAS Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Phaos Technology Holdings (Cayman) has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include stock split. View all POAS news →
SEC Filings
Phaos Technology Holdings (Cayman) has filed 10 recent SEC filings, including 8 Form 6-K, 1 Form 20-F, 1 Form F-1/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all POAS SEC filings →
Financial Highlights
Phaos Technology Holdings (Cayman) generated $104K in revenue in FY2026, retaining a 13.1% gross margin, operating income reached -$4.9M, and net income was -$4.8M. Diluted earnings per share stood at -$0.38. The company generated -$8.6M in operating cash flow. The current ratio was 5.11, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Phaos Technology Holdings (Cayman) (POAS) currently stands at 21.7 thousand shares, representing 9.9% of the float. A stock split fell inside this reporting period, so the figure cannot be compared with the previous one.
Days to Cover History
Days to cover for Phaos Technology Holdings (Cayman) (POAS) currently stands at 1.0 days, down 76.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.3 days.
POAS Company Profile & Sector Positioning
Phaos Technology Holdings (Cayman) (POAS) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing POAS often look at related companies in the same sector, including Adagio Medical Holdings, Inc (ADGM), INVO Fertility, Inc. (IVF), Nuwellis, Inc. (NUWE), Bluejay Diagnostics, Inc. (BJDX), and IceCure Medical Ltd. (ICCM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POAS's relative position within its industry.